159 related articles for article (PubMed ID: 33207979)
1. Combined hereditary thrombophilias are responsible for poor placental vascularization development and low molecular weight heparins (LMWH) prevent adverse pregnancy outcomes in these patients.
Gojnic MG; Dugalic SV; Stefanovic AO; Stefanovic KV; Petronijevic MA; Vrzic Petronijevic SM; Pantic IV; Perovic MD; Vasiljevic BI; Milincic NM; Zaric MM; Todorovic JS; Macura M
J Matern Fetal Neonatal Med; 2022 Nov; 35(22):4346-4353. PubMed ID: 33207979
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome.
Aracic N; Roje D; Jakus IA; Bakotin M; Stefanovic V
Yonsei Med J; 2016 Sep; 57(5):1230-5. PubMed ID: 27401656
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome.
Aracic N; Roje D; Drmic Hofman I; Capkun V; Stefanovic V
J Matern Fetal Neonatal Med; 2015 Feb; 28(3):306-10. PubMed ID: 24749801
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 2 approaches in management of pregnant women with inherited trombophilias: Prospective analytical cohort study.
Dugalic S; Petronijevic M; Stefanovic A; Stefanovic K; Petronijevic SV; Stanisavljevic D; Kepeci SP; Milincic N; Pantic I; Perovic M
Medicine (Baltimore); 2019 Aug; 98(34):e16883. PubMed ID: 31441864
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia.
Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252
[TBL] [Abstract][Full Text] [Related]
6. Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial.
Llurba E; Bella M; Burgos J; Mazarico E; Gómez-Roig MD; De Diego R; Martínez-Astorquiza T; Alijotas-Reig J; Sánchez-Durán MÁ; Sánchez O; Carreras E; Cabero L
Fetal Diagn Ther; 2020; 47(11):824-833. PubMed ID: 33472201
[TBL] [Abstract][Full Text] [Related]
7. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
[TBL] [Abstract][Full Text] [Related]
8. Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.
McLaughlin K; Hobson SR; Chandran AR; Agrawal S; Windrim RC; Parks WT; Bowman AW; Sovio U; Smith GC; Kingdom JC
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1145-S1156.e1. PubMed ID: 34461078
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis.
Chen J; Huai J; Yang H
BMC Pregnancy Childbirth; 2024 Jan; 24(1):68. PubMed ID: 38233773
[TBL] [Abstract][Full Text] [Related]
10. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Areia AL; Fonseca E; Areia M; Moura P
Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
[TBL] [Abstract][Full Text] [Related]
12. Placenta-mediated pregnancy complications in women with a history of late fetal loss and placental infarction without thrombophilia: risk of recurrence and efficacy of pharmacological prophylactic interventions. A 10-year retrospective study.
Borella F; Marozio L; Bertschy G; Botta G; Bertero L; Cassoni P; Maina A; Cosma S; Benedetto C
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2183748. PubMed ID: 36860098
[TBL] [Abstract][Full Text] [Related]
13. Clinical cure of severe, early onset preeclampsia with low molecular weight heparin therapy in primigravida with hyperreactio luteinalis and thrombophilia.
Saisto T; Tiitinen A; Ulander VM; Kaaja R
Hum Reprod; 2004 Mar; 19(3):725-8. PubMed ID: 14998977
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis and treatment of thrombophilia in pregnancy.
Gris JC; Lissalde-Lavigne G; Quéré I; Dauzat M; Marès P
Curr Opin Hematol; 2006 Sep; 13(5):376-81. PubMed ID: 16888444
[TBL] [Abstract][Full Text] [Related]
15. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
16. [Thrombophilia, preeclampsia and other pregnancy complications].
Vucić N; Frleta M; Petrović D; Ostojić V
Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
[TBL] [Abstract][Full Text] [Related]
17. [ANTITHROMBOTIC MEDICATION IN PREGNANT WOMEN WITH PREVIOUS INTRAUTERINE GROWTH RESTRICTION].
Neykova K; Dimitrova V; Dimitrov R; Vakrilova L
Akush Ginekol (Sofiia); 2016; 55(2):3-9. PubMed ID: 27509650
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in an obstetrical population with hereditary thrombophilia and high tobacco use.
Calhoun B; Hoover E; Seybold D; Broce M; Hill A; Schaible B; Bracero LA
J Matern Fetal Neonatal Med; 2018 May; 31(10):1267-1271. PubMed ID: 28367651
[TBL] [Abstract][Full Text] [Related]
19. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
[TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias.
Kupferminc MJ; Fait G; Many A; Lessing JB; Yair D; Bar-Am A; Eldor A
Hypertens Pregnancy; 2001; 20(1):35-44. PubMed ID: 12044312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
